There is more heterogeneity amongst AML subtypes, most notably for AML with MLL (11q23) where the 5-year RS were 47.1% (16.0–72.9%) and 22.9% (5.9–46.5%) for males and females respectively. The gene discussed is KMT2A; the disease is acute myeloid leukemia.